Chinese Journal of New Drugs and Clinical Remedies
|
2024, 43(1): 75-78
• Rational Drug Use •
A case of recurrent and refractory diffuse large B-cell lymphoma by sequential allogeneic transplantation with polatuzumab vedotin combined with BR regimen chemotherapy
Full
Hua YANG
, Hui-jun LI, Jin-hui HE, Miao-ling QIU, Si-wan ZHANG, Xiao-ling QIU, Jia-cai ZHUO, Xiao-juan AN, Jun WANG, Zhi-mei ZHU, Qing WANG, Bao LI
Affiliations
- Department of Hematology and Bone Marrow Transplantation Laboratory, the University of Hong Kong-Shenzhen Hospital, Shenzhen GUANGDONG 518000, China
Published: 2024-01-25
doi: 10.14109/j.cnki.xyylc.2024.01.14
Outline
lymphoma, large B-cell, diffuse
/
polatuzumab vedotin
/
hematopoietic stem cell transplantation
杨华, 李回军, 何金辉, 丘妙玲, 张思婉, 邱小玲, 卓家才, 安晓娟, 王钧, 朱知梅, 王清, 李宝.
维泊妥珠单抗联合BR方案桥接异基因移植治疗复发难治性弥漫大B细胞淋巴瘤1例.
中国新药与临床杂志,
2024
, 43
(1)
: 75
-78
.
DOI: 10.14109/j.cnki.xyylc.2024.01.14
Hua YANG, Hui-jun LI, Jin-hui HE, Miao-ling QIU, Si-wan ZHANG, Xiao-ling QIU, Jia-cai ZHUO, Xiao-juan AN, Jun WANG, Zhi-mei ZHU, Qing WANG, Bao LI.
A case of recurrent and refractory diffuse large B-cell lymphoma by sequential allogeneic transplantation with polatuzumab vedotin combined with BR regimen chemotherapy[J].
Chinese Journal of New Drugs and Clinical Remedies,
2024
, 43
(1)
: 75
-78
.
DOI: 10.14109/j.cnki.xyylc.2024.01.14
Year 2024 volume 43 Issue 1
630
320
Cite this Article
BibTeX
Article Info
doi: 10.14109/j.cnki.xyylc.2024.01.14
- Receive Date:2022-06-13
- Online Date:2026-03-19
- Published:2024-01-25